About US
Contact us
-
GSK notches Zantac win in Illinois, appeals high-stakes setback in DelawareAs the year rolls on, GSK continues to knock out personal injury lawsuits in the long-running legal saga over whether the popular heartburn medication Zantac can cause cancer. Plaintiff Eugenia Kasza2024/5/7
-
US Supreme Court rejects Vanda's bid to revive patents on sleep disorder drug HetliozThe prospects for Vanda Pharmaceuticals’ 10-year-old circadian rhythm drug Hetlioz have grown that much dimmer after the U.S. Supreme Court shot down the company’s attempt to challenge an appeals cou2024/4/25
-
With $380M deal, Bristol Myers Squibb ups the ante with cell therapy manufacturer CellaresBristol Myers Squibb was the first major biopharma company to take notice of innovative cell therapy contract manufacturer Cellares, participating in a $255 million series C funding round in August o2024/4/25
-
CSL Vifor proposes campaign to undo messaging about safety profile of rival productCSL Vifor hasproposedto launch a campaign that would undo the potentially misleading messages it sent about the safety of a rival product, the European Commission (EC) said. The initiative comes near2024/4/23
-
Roche snags postsurgery FDA nod for Alecensa, eyes even broader lung cancer useRoche isn’t content with Alecensa being the best-selling ALK inhibitor in metastatic lung cancer. The Swiss pharma has now secured FDA approval in the post-surgical setting as it continues to test th2024/4/23
-
Shinobi strikes deal with electronics powerhouse Panasonic to create new cell therapy manufacturing platformHistory is coming full circle as induced pluripotent stem (iPS) cell-derived cell therapy maker Shinobi Therapeutics links up with Panasonic and Japan’s Kyoto University, where the first mouse iPS ce2024/4/18
-
After coming up short in COVID, Valneva focuses on chikungunya vaccine launchAfter striking out in an attempt to create a niche for its COVID-19 vaccine, Valneva is taking its swings at what it does best—developing, manufacturing and commercializing vaccines for a variety of2024/4/18
-
Vanda turns back on hostile takeover bid by CDMO Future PakTwo weeks after gaining a hard-earned FDA label expansion for its long-established antipsychotic drug Fanapt (iloperidone), Vanda Pharmaceuticals has derailed a hostile takeover bid. By employing a s2024/4/16
-
UPDATED: Novo Nordisk attracts lawmakers' scrutiny after dropping discounted insulin product LevemirNovo Nordisk is receiving pushback from a trio of lawmakers over its decision to discontinue its long-acting insulin product Levemir, which was due for a steep discount at the start of the new year.2024/4/16
-
AbbVie touts Rinvoq win in giant cell arteritis, potentially teeing up another label expansionLess than a year ago, AbbVie's star immunology drug Rinvoqpicked up its seventh FDA approvalwhen the agency endorsed it in Crohn's disease. After a new positive pivotal trial, the drug could be bound2024/4/11